Angewandte
Communications
Chemie
efficient, size-selective, and recyclable catalytic performance
for the Suzuki–Miyaura cross-coupling reaction of phenyl-
boronic acid and a series of aryl bromides.
A fragmented ligand is often used either as a modula-
tor[15,16] or as a defect-generating dopant[16–18] during the
synthesis of MOFs. Since MOF-74 does not allow function-
alized DOBDC in the framework, we used a functionalized
DOBDC fragment as a dopant during the de novo synthesis
of the amine-tagged defective MOF-74. Recently, several
mixed-ligand M-MOF-74 (M = Mg, Mn, Co, and Ni) deriva-
tives have been synthesized by doping 2-hydroxy-1,4-benze-
nedicarboxylate (BDC-OH).[19–21] Conversely, fragmented
carboxylate ligands without hydroxy groups can only be
doped into the framework at very low concentrations. This
suggests that the two functional groups of DOBDC, namely
-OH and -COOH, are required to participate simultaneously
in the assembly of the mixed-ligand M-MOF-74. However,
attempts to coassemble salicylate (SA) in Mn-MOF-74 was
not successful.[20] Meanwhile, in the reaction of zinc and
H4DOBDC in the presence of salicylic acid (H2SA), the H2SA
only acted as a modulator, and Zn-MOF-74 grew in the form
of a nanosized rod.[22] With this information, we attempted to
find doping conditions, using H2SA as a fragmented ligand,
since many salicylic acid derivatives with diverse functional
groups are available. As functionalized fragments, we judi-
ciously chose 5- and 3-aminosalicylic acid because an amino
group is suitable for further covalent PSM with many organic
functional groups.[23,24]
All attempts to incorporate an SA, as a fragmented ligand,
into the framework of M-MOF-74 (M = Mg, Mn, Co, and Zn)
were unsuccessful (Figures S1 and S2). In contrast, in the case
of Ni-MOF-74, the SA-incorporated DEMOF-I (I-SAx,
where I and x represent Ni-MOF-74 and the mole fraction
of the integrated SA at the DOBDC ligand sites of the
framework, respectively) was successfully synthesized in
a DMF/EtOH/H2O (15:1:1, v/v/v) solvent mixture (Figures
S3–S10). This approach is also effective for introducing 3-aSA
or 5-aSA into the framework of Ni-MOF-74, thereby resulting
in amine-tagged DEMOF-I (denoted as I-n-aSAx, where n-
aSA and x represent the integrated n-aSA and the mole
fraction of the integrated n-aSA at the DOBDC sites of the
framework, respectively). I-SAx and I-5-aSAx retained good
crystallinity up to a fragment mole fraction of approximately
20% (Figures 1a, S5, and S11), whereas I-3-aSAx retained its
crystallinity, but its crystallinity was inferior to I-SAx and I-5-
aSAx (Figures S6, S12, and S13).
Figure 1. a) PXRD patterns and b) N2 sorption isotherms of Ni-MOF-
74 and I-5-aSAx at 77 K.
was the same as that of the pristine Ni-MOF-74. This finding
is related to the increase in the number of defect sites.
The amino group on I-5-aSA0.20 can be covalently
modified through a Schiff-base condensation reaction. The
reaction of I-5-aSA0.20 with 2-formylpyridine produced I-5-
pSA0.20 containing a 5-(pyridin-2-ylmethylene)amino group
(Figure S17a). The Pd-incorporated DEMOF-I, I-5-pSA0.20
-
Pd0.05, can be obtained through post-synthetic metalation.[25]
The Pd-incorporated MOFs preserved their crystallinity after
the entire PSM procedure (Figure 2a). Transmission electron
microscopy (TEM) and energy-dispersive spectroscopy
(EDS) showed that the Pd atoms were considerably dispersed
in I-5-pSA0.20-Pd0.05 (Figure 2c–e). I-3-pSA0.18 and I-3-pSA0.18
-
Pd0.07 can also be obtained by the same procedure using I-3-
aSA0.18 (Figures S17b, S18, and S19). X-ray photoelectron
spectroscopy (XPS) data support the presence of PdII ions in
I-3-pSA0.18-Pd0.07 (Figure S20). The covalent PSM of the
amine-tagged DEMOF-I and subsequent metalation of the
framework slightly reduced the pore volume of the corre-
sponding MOF (Figures 2b, S21a, and Table S1). The doping
of n-aSA led to a significant broadening of the pore-size
distribution of the MOFs (Figures S21b and S22), which
suggests that the enlargement and reduction of the local pore
dimension occurred simultaneously around the defect sites.
More interestingly, the covalent PSM had a different effect on
the pore-size distributions of the modified DEMOFs. The
functionalization of both amine-substituted SAs led to
a narrow pore-size distribution of the MOFs. Conversely,
while the functionalization of the 3-aSA residue mainly
reduced the size of the relatively large pores, the function-
alization of the 5-aSA residue predominantly reduced the size
of the relatively small pores. Thus, MOFs with different
average pore dimensions were produced. The average pore
size of I-3-pSA0.18-Pd0.07 ( ꢀ 10 ꢀ) and I-5-pSA0.20-Pd0.05
( ꢀ 12 ꢀ) is slightly smaller and larger than that of the pristine
Ni-MOF-74 ( ꢀ 11 ꢀ), respectively.
As expected, the doping of the fragment affected the
porosities of the resulting amine-tagged DEMOF-I. Interest-
ingly, the doping of 5-aSA led to an increase in the porosity of
I-5-aSAx compared to pristine Ni-MOF-74 (Figure 1b and
Table S1), even above a doping level of 30%. In contrast, the
amount of N2 absorbed in I-SAx and I-3-aSAx slightly
increased only at relatively low mole fractions of fragments
(Figures S14a, and S15a). The pristine Ni-MOF-74 and
amine-tagged DEMOF-I showed almost the same mean
pore diameters that peaked at 11 ꢀ (Figures S14b, S15b, and
S16). As the mole fraction of n-aSA increased, the pore-size
distribution became wider, while the average pore dimension
Although there are no reports of the covalent modifica-
tion of DOBPDC in Ni2(DOBPDC), an extended analogue of
Angew. Chem. Int. Ed. 2021, 60, 9296 –9300
ꢀ 2021 Wiley-VCH GmbH